News Headlines Article

‘Don’t eat me’ cancer drug work at Stanford wins $12.7 million CIRM grant
San Francisco Business Times

A team led by Stanford University researcher Irv Weissman won a $12.7 million grant from California’s stem cell funding agency Thursday to go into human clinical trials next year with a drug that could break down a barrier that protects cancer stem cells from being eliminated by the immune system.

The award is one of six totaling $61.1 million from the San Francisco-based California Institute for Regenerative Medicine — and the only one from the Bay Area — handed out Thursday. The winners’ treatments target diseases like sickle cell disease and the blinding eye disease called macular degeneration.